Head and Neck Tumor
8
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
MRI-based Synthetic CT Images of the Head and Neck
Effectiveness of Care in Certified Cancer Centres in Germany
In-Room PET in Proton Radiation Therapy
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor